• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    3/1/23 1:16:45 PM ET
    $ADMP
    $AMC
    $AMPH
    $AMPY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Movies/Entertainment
    Consumer Discretionary
    Get the next $ADMP alert in real time by email

    Gainers

    • Reata Pharmaceuticals Inc (NASDAQ:RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
    • OncoSec Medical Incorporated (NASDAQ:ONCS) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time.
    • HPX Corp. (NYSE:HPX) gained 51.3% to $14.96.
    • Lucira Health, Inc. (NASDAQ:LHDX) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test.
    • Nerdy, Inc. (NYSE:NRDY) surged 29.6% to $3.2550 following better-than-expected Q4 results.
    • Helbiz Inc (NASDAQ:HLBZ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday.
    • B&G Foods, Inc. (NYSE:BGS) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results.
    • Red Robin Gourmet Burgers, Inc. (NASDAQ:RRGB) gained 25.5% to $10.64 after the company reported Q4 results.
    • Sarepta Therapeutics Inc (NASDAQ:SRPT) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.
    • Schrödinger, Inc. (NASDAQ:SDGR) gained 19.3% to $25.91 following strong Q4 results.
    • Dycom Industries, Inc. (NYSE:DY) gained 18.4% to $99.72 after the company reported better-than-expected Q4 sales results.
    • China Pharma Holdings Inc (NASDAQ:CPHI) rose 17.4% to $0.0792. China Pharma recently announced a 1-for-10 reverse stock split.
    • PetIQ, Inc. (NASDAQ:PETQ) gained 17% to $10.90 following Q4 results.
    • Clarivate Plc (NYSE:CLVT) surged 17% to $11.85 following strong quarterly results.
    • Duolingo, Inc. (NASDAQ:DUOL) rose 16.3% to $105.68 after the company reported better-than-expected Q4 results.
    • OneSpan Inc. (NASDAQ:OSPN) jumped 16.3% to $15.72 following upbeat Q4 results.
    • 3D Systems Corporation (NYSE:DDD) gained 16.2% to $11.38 after posting a narrower-than-expected quarterly loss.
    • Amplify Energy Corp. (NYSE:AMPY) rose 15.3% to $9.66. Amplify Energy entered into $96.5 million Settlement with the shipping companies related to containerships' anchor strikes of pipeline.
    • CarGurus, Inc. (NASDAQ:CARG) rose 15.3% to $19.66 following strong quarterly results.
    • Puyi Inc. (NASDAQ:PUYI) gained 14.5% to $8.30.
    • Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) jumped 14.5% to $36.51 following Q4 results.
    • Gulfport Energy Corporation (NASDAQ:GPOR) gained 13.4% to $74.98 following Q4 results.
    • IVERIC bio, Inc. (NASDAQ:ISEE) jumped 13% to $23.52 following Q4 results.
    • Myriad Genetics, Inc. (NASDAQ:MYGN) gained 12.4% to $21.28 after reporting strong quarterly results.
    • OKYO Pharma Limited (NASDAQ:OKYO) shares gained 9.9% to $2.45. US Customs cleared OKYO Pharma's GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.

    Losers

    • Performance Shipping Inc. (NASDAQ:PSHG) shares tumbled 58.4% to $1.12 after the company reported pricing of $12.5 million registered direct offering of 5.556 million shares of common stock at a price of $2.25 per share.
    • Xometry, Inc. (NASDAQ:XMTR) fell 40.5% to $18.08 after the company announced downbeat quarterly results.
    • iHeartMedia, Inc. (NASDAQ:IHRT) fell 32% to $4.93 after the company posted Q4 results.
    • Montrose Environmental Group, Inc. (NYSE:MEG) dropped 30.4% to $33.86 following weak quarterly sales.
    • China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) dipped 30.2% to $5.21.
    • National Vision Holdings, Inc. (NASDAQ:EYE) dropped 29% to $26.50 following downbeat Q4 results.
    • Novavax Inc (NASDAQ:NVAX) fell 27.6% to $6.70 after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.
    • FIGS, Inc. (NYSE:FIGS) dipped 24% to $6.99 after the company reported Q4 results.
    • Bright Health Group, Inc. (NYSE:BHG) fell 22.4% to $0.6753 following Q4 results.
    • Invitae Corporation (NYSE:NVTA) dropped 22.2% to $1.6716 following Q4 results.
    • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) fell 20.8% to $0.1780. Adamis Pharmaceuticals and DMK Pharmaceuticals Corp entered into an Agreement and Plan of Merger and Reorganization.
    • Marqeta Inc (NASDAQ:MQ) fell 21.1% to $4.5750 after the company reported fourth-quarter results and issued guidance for slowing growth.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 19.7% to $1.10.
    • Compass, Inc. (NYSE:COMP) dropped 18.8% to $2.9301 after the company reported worse-than-expected Q4 results and issued weak Q1 guidance.
    • Myers Industries, Inc. (NYSE:MYE) fell 18.4% to $21.08 following weak sales.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) dipped 16.1% to $4.8150 after the space travel company reported mixed fourth-quarter results.
    • Clean Energy Fuels Corp. (NASDAQ:CLNE) fell 14.5% to $4.7850 following weak sales.
    • Infobird Co., Ltd (NASDAQ:IFBD) dropped 14.3% to $0.6851. Infobird recently announced pricing of a $5 million registered direct offering,
    • Catalyst Biosciences Inc (NASDAQ:CBIO) fell 13.4% to $0.2572. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.
    • Brightspire Capital Inc (NYSE:BRSP) fell 13.3% to $6.40 after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.
    • MBIA Inc. (NYSE:MBI) dropped 13.2% to $11.97 following Q4 results.
    • First Horizon Corporation (NYSE:FHN) declined 12.6% to $21.64.
    • Wallbox N.V. (NYSE:WBX) fell 12.4% to $4.9614 following quarterly results.
    • Cerus Corporation (NASDAQ:CERS) dipped 12.4% to $2.5050 following weak quarterly results.
    • Arbe Robotics Ltd. (NASDAQ:ARBE) fell 9.7% to $6.30.
    • Obseva SA (NASDAQ:OBSV) shares dropped 8.8% to $0.1259 after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
    • Beamr Imaging Ltd. (NASDAQ:BMR) shares fell 8.2% to $3.35. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.
    • AMC Entertainment Holdings Inc (NYSE:AMC) shares fell 5.2% to $6.76 after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.

    Now Read This: Seagen, Delta Air Lines And 2 Other Stocks Insiders Are Selling

    Get the next $ADMP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADMP
    $AMC
    $AMPH
    $AMPY

    CompanyDatePrice TargetRatingAnalyst
    Compass Inc.
    $COMP
    3/26/2026$14.00Buy
    The Benchmark Company
    Gulfport Energy Corporation
    $GPOR
    3/24/2026$230.00Hold
    Truist
    FIGS Inc.
    $FIGS
    3/20/2026$22.00Perform → Outperform
    Oppenheimer
    Duolingo Inc.
    $DUOL
    3/18/2026Buy → Hold
    Argus
    Dycom Industries Inc.
    $DY
    3/10/2026$436.00Overweight
    Cantor Fitzgerald
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Hold
    Truist
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Neutral
    BofA Securities
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Sector Outperform → Sector Perform
    Scotiabank
    More analyst ratings

    $ADMP
    $AMC
    $AMPH
    $AMPY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Pittman Robert W bought $48,525 worth of shares (16,349 units at $2.97), increasing direct ownership by 0.26% to 6,231,286 units (SEC Form 4)

    4 - iHeartMedia, Inc. (0001400891) (Issuer)

    3/9/26 8:40:47 PM ET
    $IHRT
    Broadcasting
    Consumer Discretionary

    President and CEO Raha Samraat S. bought $199,844 worth of shares (40,000 units at $5.00), increasing direct ownership by 9% to 493,104 units (SEC Form 4)

    4 - MYRIAD GENETICS INC (0000899923) (Issuer)

    3/9/26 7:03:13 PM ET
    $MYGN
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Chairman and CEO Pittman Robert W bought $105,576 worth of shares (32,468 units at $3.25), increasing direct ownership by 0.53% to 6,214,937 units (SEC Form 4)

    4 - iHeartMedia, Inc. (0001400891) (Issuer)

    3/5/26 5:00:04 PM ET
    $IHRT
    Broadcasting
    Consumer Discretionary

    $ADMP
    $AMC
    $AMPH
    $AMPY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Benchmark Company initiated coverage on Compass with a new price target

    The Benchmark Company initiated coverage of Compass with a rating of Buy and set a new price target of $14.00

    3/26/26 8:47:49 AM ET
    $COMP
    EDP Services
    Technology

    Truist initiated coverage on Gulfport Energy with a new price target

    Truist initiated coverage of Gulfport Energy with a rating of Hold and set a new price target of $230.00

    3/24/26 8:39:43 AM ET
    $GPOR
    Oil & Gas Production
    Energy

    FIGS, Inc. upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded FIGS, Inc. from Perform to Outperform and set a new price target of $22.00

    3/20/26 8:28:51 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $ADMP
    $AMC
    $AMPH
    $AMPY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADMP
    $AMC
    $AMPH
    $AMPY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ridgetech, Inc. Announces 1-for-150 Reverse Share Split

    HANGZHOU, China, April 3, 2026 /PRNewswire/ -- Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (NASDAQ:RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-150 reverse share split on its ordinary shares ("Ordinary Shares") effective Tuesday, April 7, 2026 at 5:00 p.m. Eastern Time, with trading to begin on a split‑adjusted basis at the market open on the next trading day. Trading in the Ordinary Shares will continue on the Nasdaq Capital Market under the symbol "RDGT." The new CUSIP number for the Ordinary Shares following the reverse share split is G2124G 203. As of April 2, 2026, the

    4/3/26 12:00:00 PM ET
    $CJJD
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    First Horizon Bank and New Orleans Jazz & Heritage Festival Celebrate 11 Years of Partnership: New First Horizon Lounge Debuts Near Main Stage for Cardholders

    NEW ORLEANS, April 2, 2026 /PRNewswire/ -- First Horizon Bank (NYSE:FHN, First Horizon", )) and the New Orleans Jazz & Heritage Festival today celebrate their long-standing partnership and its economic impact across the New Orleans region in support of the music, culture and community spirit that make Jazz Fest one of the South's premiere events. New this year, First Horizon is expanding its sponsorship as the "Official Bank and Credit Card of Jazz Fest" with an exclusive Lounge experience. The First Horizon Lounge, located near the Festival and Congo Square stages, is available

    4/2/26 12:00:00 PM ET
    $FHN
    Major Banks
    Finance

    BrightSpire Capital, Inc. Announces First Quarter 2026 Earnings Release and Conference Call Dates

    BrightSpire Capital, Inc. (NYSE:BRSP) ("BrightSpire Capital" or the "Company") today announced it will release first quarter 2026 financial results on Tuesday, April 28, 2026, after the market closes. The Company will conduct a conference call to discuss the results on Wednesday, April 29, 2026, at 10:00 a.m. ET / 7:00 a.m. PT. To participate in the event by telephone, please dial (833) 821-4389 ten minutes prior to the start time (to allow time for registration). International callers should dial (412) 652-1257. The call will also be broadcast live over the Internet and can be accessed on the ‘Shareholders' section of the Company's website at www.brightspire.com. A webcast of the call wi

    4/2/26 8:30:00 AM ET
    $BRSP
    Real Estate Investment Trusts
    Real Estate

    $ADMP
    $AMC
    $AMPH
    $AMPY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hodges Michael L

    4 - GULFPORT ENERGY CORP (0000874499) (Issuer)

    4/3/26 6:17:43 PM ET
    $GPOR
    Oil & Gas Production
    Energy

    SEC Form 4 filed by Martinez Jason Joseph

    4 - GULFPORT ENERGY CORP (0000874499) (Issuer)

    4/3/26 6:17:34 PM ET
    $GPOR
    Oil & Gas Production
    Energy

    SEC Form 3 filed by new insider Secrist Bradley Neil

    3 - GULFPORT ENERGY CORP (0000874499) (Issuer)

    4/3/26 6:17:23 PM ET
    $GPOR
    Oil & Gas Production
    Energy

    $ADMP
    $AMC
    $AMPH
    $AMPY
    SEC Filings

    View All

    SEC Form DEFA14A filed by Compass Inc.

    DEFA14A - Compass, Inc. (0001563190) (Filer)

    4/3/26 4:38:04 PM ET
    $COMP
    EDP Services
    Technology

    SEC Form DEF 14A filed by Compass Inc.

    DEF 14A - Compass, Inc. (0001563190) (Filer)

    4/3/26 4:37:09 PM ET
    $COMP
    EDP Services
    Technology

    SEC Form DEFA14A filed by B&G Foods Inc.

    DEFA14A - B&G Foods, Inc. (0001278027) (Filer)

    4/3/26 4:07:51 PM ET
    $BGS
    Packaged Foods
    Consumer Staples

    $ADMP
    $AMC
    $AMPH
    $AMPY
    Leadership Updates

    Live Leadership Updates

    View All

    Dycom Industries, Inc. Appoints Company Veteran Bo Gresham as its First Chief Revenue Officer to Lead Next Phase of Growth

    WEST PALM BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE:DY) today announced the appointment of James "Bo" Gresham as the company's first Chief Revenue Officer (CRO), effective March 30, 2026. Mr. Gresham will lead the company's unified revenue organization with a focus on scaling strategic market expansion and strengthening relationships with key stakeholders for Dycom's next chapter of growth. Mr. Gresham, a seasoned industry leader and U.S. Army veteran, brings nearly three decades of operational and strategic experience to the role. Since joining the corporate leadership team in 2023 as Vice President of Strategy, he has been a key contributor to the co

    3/31/26 4:45:33 PM ET
    $DY
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

    Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline  GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi

    3/30/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dycom Industries, Inc. Appoints Raejeanne Skillern to Board of Directors

    WEST PALM BEACH, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE:DY) today announced the appointment of Raejeanne Skillern to its Board of Directors, effective March 24, 2026. Ms. Skillern is a highly regarded technology executive with over 30 years of leadership experience spanning hyperscale cloud, data center infrastructure, communications and artificial intelligence. She has a proven track record of leading multi-billion-dollar business units at global organizations including Amazon Web Services (AWS), Intel and Flex. "We are pleased to welcome Raejeanne to the Dycom Board of Directors," said Richard K. Sykes, Dycom's Independent Chairman of the Board. "Her de

    3/24/26 4:30:00 PM ET
    $DY
    $JBL
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials
    Electrical Products
    Technology

    $ADMP
    $AMC
    $AMPH
    $AMPY
    Financials

    Live finance-specific insights

    View All

    BrightSpire Capital, Inc. Announces First Quarter 2026 Earnings Release and Conference Call Dates

    BrightSpire Capital, Inc. (NYSE:BRSP) ("BrightSpire Capital" or the "Company") today announced it will release first quarter 2026 financial results on Tuesday, April 28, 2026, after the market closes. The Company will conduct a conference call to discuss the results on Wednesday, April 29, 2026, at 10:00 a.m. ET / 7:00 a.m. PT. To participate in the event by telephone, please dial (833) 821-4389 ten minutes prior to the start time (to allow time for registration). International callers should dial (412) 652-1257. The call will also be broadcast live over the Internet and can be accessed on the ‘Shareholders' section of the Company's website at www.brightspire.com. A webcast of the call wi

    4/2/26 8:30:00 AM ET
    $BRSP
    Real Estate Investment Trusts
    Real Estate

    First Horizon Corporation Announces Redemption of Series C Preferred Stock and Corresponding Series C Depositary Shares

    MEMPHIS, Tenn., April 1, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE:FHN) today announced that on May 1, 2026 (the "Redemption Date"), it will redeem all outstanding shares of its 6.600% Fixed-to-Floating Non-Cumulative Perpetual Preferred Stock, Series C (the "Series C Preferred Stock"), and all related outstanding depositary shares, each representing a 1/400th interest in a share of the Series C Preferred Stock ("the Series C Depositary Shares") (NYSE:FHN). After the redemptions, no shares of Series C Preferred Stock, and no Series C Depositary Shares, will remain outstanding.

    4/1/26 6:45:00 AM ET
    $FHN
    Major Banks
    Finance

    Myers Industries Announces Reporting Date and Conference Call for 2026 First Quarter Results

    Myers Industries, Inc. (NYSE:MYE) today announced that it will report financial results for the first quarter on Thursday, May 7, 2026, before the market opens. The Company will host a conference call the same day at 10:00 a.m. Eastern Time to review its performance. Investors and analysts may access the call using the online participation registration link. Upon registering, each participant will be provided with call details and a registrant ID. Reminders will also be sent to registered participants via email. Alternatively, the conference call will be available via a live webcast. To access the live webcast, visit the Company's website www.myersindustries.com and click on the Investor

    3/31/26 5:00:00 PM ET
    $MYE
    Plastic Products
    Industrials

    $ADMP
    $AMC
    $AMPH
    $AMPY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Montrose Environmental Group Inc.

    SC 13G - Montrose Environmental Group, Inc. (0001643615) (Subject)

    12/17/24 4:20:32 PM ET
    $MEG
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Myers Industries Inc.

    SC 13D/A - MYERS INDUSTRIES INC (0000069488) (Subject)

    12/13/24 4:12:08 PM ET
    $MYE
    Plastic Products
    Industrials

    Amendment: SEC Form SC 13G/A filed by Clarivate Plc

    SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

    12/5/24 10:02:09 AM ET
    $CLVT
    EDP Services
    Technology